Category: Medications - Page 4

Tirzepatide for Weight Loss: How Dual Incretin Therapy Works and What to Expect
Mark Jones 15 December 2025 10 Comments

Tirzepatide for Weight Loss: How Dual Incretin Therapy Works and What to Expect

Tirzepatide (Zepbound) is a dual incretin therapy that targets both GLP-1 and GIP receptors to promote significant weight loss. It outperforms older GLP-1 drugs like semaglutide, with users losing up to 22.4% of body weight. Learn how it works, what to expect, and who it's for.

NSAID Overdose: How to Recognize and Prevent Gastrointestinal Bleeding
Mark Jones 7 December 2025 11 Comments

NSAID Overdose: How to Recognize and Prevent Gastrointestinal Bleeding

NSAID overdose can cause silent, life-threatening gastrointestinal bleeding-even without pain. Learn who’s at risk, how to spot hidden bleeding, and what to do to protect yourself.

What Happens When You Don't Take Your Medication as Prescribed
Mark Jones 4 December 2025 15 Comments

What Happens When You Don't Take Your Medication as Prescribed

Skipping your prescribed medication might seem harmless, but it leads to preventable hospitalizations, deaths, and billions in healthcare costs. Learn the real risks and what you can do to stay on track.

DSCSA Track-and-Trace: How It Stops Counterfeit Drugs Before They Reach You
Mark Jones 3 December 2025 11 Comments

DSCSA Track-and-Trace: How It Stops Counterfeit Drugs Before They Reach You

The DSCSA track-and-trace system is the U.S. government’s final defense against counterfeit drugs. By 2024, every prescription package must have a unique digital ID. Here’s how it works, who it affects, and why it matters.

Metoclopramide and Antipsychotics: The Hidden Risk of Neuroleptic Malignant Syndrome
Mark Jones 2 December 2025 15 Comments

Metoclopramide and Antipsychotics: The Hidden Risk of Neuroleptic Malignant Syndrome

Metoclopramide and antipsychotics can trigger Neuroleptic Malignant Syndrome-a rare but deadly condition. Learn why this interaction is so dangerous, who’s at risk, and what safer alternatives exist.

How to Prevent Wrong-Dose Errors with Liquid Medications: A Practical Guide for Caregivers and Clinicians
Mark Jones 1 December 2025 13 Comments

How to Prevent Wrong-Dose Errors with Liquid Medications: A Practical Guide for Caregivers and Clinicians

Wrong-dose errors with liquid medications are common and dangerous, especially for children. Learn how oral syringes, metric-only labeling, and electronic systems can prevent these errors-and what caregivers and clinicians must do today to stay safe.

Long-Term Health After Switching to Generics: What Really Happens After a Year?
Mark Jones 1 December 2025 13 Comments

Long-Term Health After Switching to Generics: What Really Happens After a Year?

Switching to generic medications saves money, but long-term health outcomes aren't always guaranteed. Learn how manufacturing differences, inconsistent sourcing, and pill changes can affect your condition over time - and what steps to take to stay safe.

Bulk Purchasing and Discounts: How Large-Scale Procurement of Generic Medications Lowers Costs
Mark Jones 24 November 2025 10 Comments

Bulk Purchasing and Discounts: How Large-Scale Procurement of Generic Medications Lowers Costs

Bulk purchasing of generic medications can cut drug costs by 20-25% for clinics and providers. Learn how volume discounts, short-dated stock, and secondary distributors work-and how to start saving today.

FDA Boxed Warnings Explained: What You Need to Know Before Taking High-Risk Medications
Mark Jones 21 November 2025 14 Comments

FDA Boxed Warnings Explained: What You Need to Know Before Taking High-Risk Medications

FDA boxed warnings, or black box warnings, are the strongest safety alerts for prescription drugs. Learn what they mean, which medications carry them, and how to stay safe without avoiding necessary treatment.

Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Launch
Mark Jones 19 November 2025 8 Comments

Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Launch

Paragraph IV certifications let generic drug makers challenge brand-name patents before launch, speeding up affordable drug access. Learn how this legal tool saves billions and reshapes the pharmaceutical market.